[Prostate carcinoma: vaccination as a new option for treatment]
/in Dendritic Cells, International Publications, Prostate Cancer /von 2012-01-01 / Urologe A 2012 Jan;51(1):44-9Immunotherapy of lung adenocarcinoma patient with Peptide-pulsed dendritic cells: a case report
/in Dendritic Cells, International Publications, NSCLC /von 2011-12-06 / Arch. Immunol. Ther. Exp. (Warsz.) 2012 Feb;60(1):69-77Immunotherapy for glioma: getting closer to the clinical arena?
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-12-01 / Curr. Opin. Neurol. 2011 Dec;24(6):641-7Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-11-26 / Vaccine 2012 Jun;30(29):4394-7Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8+ T cells
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-11-23 / Int. J. Oncol. 2012 Mar;40(3):764-72Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2011-11-16 / Cancer Immunol. Immunother. 2012 Jun;61(6):865-79Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-11-07 / World Neurosurg 2012 May-Jun;77(5-6):736-44Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients
/in Dendritic Cells, International Publications /von 2011-11-02 / J. Immunol. 2011 Dec;187(11):6130-42Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2011-11-01 / Anticancer Res. 2011 Nov;31(11):3995-4005IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de